Erleada (Apalutamide Tablet) 60mg

Apalutamide 60mg tablets are used to treat certain types of prostate cancer. This oral medication helps manage disease progression in specific patient groups. It is available in a 112-tablet pack for consistent therapy. Store at room temperature for convenience.

Strength

60mg

Pack Size

112s

Storage

Ambient

Manufacturer / TM Owner

Janssen - Cilag AG

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Apalutamide 60mg tablets are prescribed for patients with non-metastatic castration-resistant prostate cancer or metastatic hormone-sensitive prostate cancer. It works by blocking androgen receptor signals to slow cancer growth. This medication is part of a broader treatment plan for prostate cancer management. Patients often ask, 'what is Apalutamide 60mg used for' to understand its role in therapy.

Side Effects

Apalutamide 60mg tablets may cause fatigue, skin rashes, or diarrhea in some users. These effects vary by individual and are typically monitored by healthcare providers. Some patients report joint or muscle discomfort during treatment. Regular follow-ups help assess tolerance and adjust care as needed.

Precautions & Warnings

Keep Apalutamide 60mg tablets in their original packaging at room temperature, away from moisture and direct light. Avoid crushing or splitting tablets unless directed by a healthcare professional. Inform your doctor about all medications and supplements you take before starting this treatment. Store securely to prevent accidental exposure.

Avoid Interactions

Apalutamide 60mg may interact with medications that affect liver enzymes, such as certain antifungals or antibiotics. Combining it with strong CYP3A4 inducers can reduce its effectiveness. Alcohol and grapefruit products may also influence how the body processes this drug. Always discuss potential interactions with your healthcare provider.

Frequently Asked Questions

Apalutamide 60mg tablets are used to treat certain types of prostate cancer, including non-metastatic castration-resistant and metastatic hormone-sensitive prostate cancer.

Store Apalutamide 60mg tablets at room temperature in their original packaging, away from moisture, light, and out of reach of children.

Common effects may include fatigue, skin rashes, or diarrhea. These vary by individual and should be reported to a healthcare provider if persistent.

No, Apalutamide 60mg is an oral androgen receptor inhibitor, not a chemotherapy medication.

Apalutamide 60mg tablets are manufactured by Janssen - Cilag AG in Switzerland.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.